Teriflunomide

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Growth parameters and prematurity Low birth weight (< 2500g) Barataud-Reilhac A (Control unexposed, sick), 2019 11.66[0.49; 5.70]9823not evaluable Preterm (< 37 weeks) Barataud-Reilhac A (Control unexposed, sick), 2019 10.25[0.01; 4.12]9423not evaluable Maternal consequences Caesarean Barataud-Reilhac A (Control unexposed, sick), 2019 11.01[0.37; 2.74]25523not evaluable Neonatal disorders Neonatal medical care Barataud-Reilhac A (Control unexposed, sick), 2019 10.50[0.03; 8.44]4823not evaluable Intrauterine deaths Early intrauterine death (< 22 weeks) Barataud-Reilhac A (Control unexposed, sick), 2019 10.82[0.20; 3.44]8147not evaluable Elective/induced termination of pregnancy Barataud-Reilhac A (Control unexposed, sick), 2019 14.97[2.75; 8.99]23647not evaluable Late intrauterine deaths (> 22 weeks) Barataud-Reilhac A (Control unexposed, sick), 2019 11.56[0.09; 27.10]1047not evaluable Therapeutic terminations of pregnancy Barataud-Reilhac A (Control unexposed, sick), 2019 11.57[0.21; 11.93]2247not evaluable0.050.01.0

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons